Continuous Improvement and the Expansion of Quality ... - NCQA

Recommendations

Info

T H E S TAT E o f H E A l T H C A R E Q U A l I T y 2 0 1 1 • R E f E R E N C E S 5. American Heart Association. American Heart Association Defines ‘Ideal’ Cardiovascular Health, Sets New Goal to Focus on Improving Health Factors and Lifestyle Behaviors. January 20, 2010. http://americanheart.mediaroom.com/index.php?s=43&item=931 (March 16, 2010) 6. Nicholls, S.J., et al. 2007. Statins, High-density lipoprotein Cholesterol, and Regression of Coronary Atherosclerosis. JAMA 297(5): 499–508. 7. Heidenreich, P.A., J.G. Trogdon, et al., 2011. forecasting the future of Cardiovascular Disease in the United States: A Policy Statement from the American Heart Association. Circulation; 123(8): 933–44. 8. National Cholesterol Education Program. High Blood Cholesterol: What You Need to Know. http://www.nhlbi.nih.gov/health/public/ heart/chol/wyntk.pdf (June 2011) 9. lin, y., S.S. Mousa, N. Elshourbagy, S.A. Mousa. 2010. Current Status and future Directions in lipid Management: Emphasizing low- Density lipoproteins, High-Density lipoproteins, and Triglycerides as Targets for Therapy. Vascular Health Risk Management; 6:73–85. dIsEasE ModIfyIng antI-rHEuMatIC drug tHEraPy In rHEuMatoId artHrItIs 1. Mayo Clinic. Rheumatoid Arthritis Basics. http://www.mayoclinic.com/health/rheumatoid-arthritis/DS00020 (June 2011) 2. The Arthritis foundation. 2008. Rheumatoid arthritis fact sheet. http://www.arthritis.org/media/newsroom/media-kits/Rheumatoid_ Arthritis_fact_Sheet.pdf (June 2011) 3. Helmick, C., D. felson, R. lawrence, S. Gabriel, et al., 2008. Estimates of the Prevalence of Arthritis and other Rheumatic Conditions in the United States. Arthritis & Rheumatism, 58(1): 15–25. 4. Siegel, J. 2008. Comparative effectiveness of treatments for rheumatoid arthritis. Ann Int Med. 142(2): 162–3. 5. Goodson, N., J. Marks, M. lunt, D. Symmons. 2005. Cardiovascular Admissions and Mortality in an inception Cohort of Patients with Rheumatoid Arthritis with onset in the 1980s and 1990s. Ann Rheum Dis. 64:1595–601. 6. Centers for Disease Control and Prevention. 2005. Prevalence and Most Common Causes of Disability Among Adults—United States. MMWR Weekly. 58(16):421–6. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5816a2.htm (June 2011) 7. Donahue et al. 2008. Systematic review: comparative effectiveness and harms of disease-modifying medications for rheumatoid arthritis. Ann Int Med. 142(2):124–34. 8. Centers for Disease Control and Prevention. Arthritis: At a Glance 2011. http://www.cdc.gov/chronicdisease/resources/publications/ AAG/arthritis.htm (June 2011) 9. Agency for Healthcare Research and Quality. 2009 H-CUP: Patient and Hospital Characteristics for ICD-9-CM principle diagnosis codes(s) 714.0–714.9. http://hcup.ahrq.gov/HCUPnet.asp. (June 2011) 10. Pincus, T., l.f. Callahan. What is the natural history of rheumatoid arthritis? Rheum Dis Clin North Am. 1993; 19(1):123–51. usE of aPProPrIatE MEdICatIons for PEoPlE WItH astHMa 1. Centers for Disease Control and Prevention. 2009. Asthma—basic Information. http://www.cdc.gov/asthma/faqs.htm (June 1, 2011) 2. Akinbami, l.J., J.E. Moorman, x. liu. 2011. Asthma prevalence, health care use, and mortality: United States, 2005–2009. National Health Statistics Reports. 32: 1–15. 3. Columbia University. 2010. Best Practice Asthma Program Saves the US Healthcare System More than $4500 a Year per Child. http:// www.mailman.columbia.edu/news/best-practice-asthma-program-saves-us-healthcare-system-more-4500-year-child (May 26, 2011) 4. Asthma Regional Council. 2010. Living with Asthma in New England: Results from the 2006 BRFSS and Call-back Survey. http://www.asthmaregionalcouncil.org/uploads/Surveillance/bRfSS%20-%20living%20with%20Asthma%20in%20New%20England%20 february%202010.pdf (May 26, 2011) 5. barnett, S.b., T.A. Nurmagambetov. 2011. Costs of asthma in the United States: 2002–2007. Journal of Allergy and Clinical Immunology. 127(1): 145–52. 6. Centers for Disease Control and Prevention. 2011. Vital Signs: Asthma Prevalence, Disease Characteristics, and Self-Management Education—United States, 2001–2009. Morbidity and Mortality Weekly Report (MMWR). 60(17): 547–52. http://www.cdc.gov/mmwr/ preview/mmwrhtml/mm6017a4.htm (May 26, 2011) usE of sPIroMEtry tEstIng In tHE assEssMEnt and dIagnosIs of CoPd 1. American lung Association. 2010. Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality. http://www.lungusa. org/finding-cures/our-research/trend-reports/copd-trend-report.pdf (May 31, 2011). 2. Hanania, N. COPD 2010. http://www.chestnet.org/accp/chestsoundings/copd-2010 (May 31, 2011) 3. Global Initiative for Chronic obstructive lung Disease. 2010. Global strategy for the diagnosis, management, and prevention of COPD. www.goldcopd.com. (May 27, 2011) 4. Schneider, et al. 2009. Diagnostic accuracy of spirometry in primary care.BMC Pulmonary Medicine 9:31. 5. Anecchino, C., E. Rossi, C. fanizza, et al. 2007. Prevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general population. Int J Chron Obstruct Pulmon Dis 2 567–74. 6. Joo, M.J., D.H. Au, T.A. lee. 2009. Use of Spirometry in the Diagnosis of CoPD and Efforts to Improve Quality of Care. Transl Res 154:103–10. 189
190 N AT I o N A l C o M M I T T E E f o R Q U A l I T y A S S U R A N C E 7. lin, k., b. Watkins, T. Johnson, J.A. Rodriguez, M.b. barton. 2008. Screening for chronic obstructive pulmonary disease using spirometry: summary of the evidence for the U.S. Preventive Services Task force. Ann Intern Med 148:535–43. 8. U.S. Preventive Services Task force. 2008. Screening for chronic obstructive pulmonary disease. Ann Intern Med 148:529–34. PHarMaCotHEraPy ManagEMEnt of CoPd ExaCErbatIon 1. American lung Association. 2010. Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality. http://www.lungusa. org/finding-cures/our-research/trend-reports/copd-trend-report.pdf (May 27, 2011) 2. Anzueto, A. 2010. Impact of exacerbations on CoPD. Eur Respir Rev 19:116 113–18. 3. Menzin J., l. boulanger, J. Marton, l. Guadagno, H. Dastani, R. Dirani, A. Phillips, H. Shah. 2008. The economic burden of chronic obstructive pulmonary disease (CoPD) in a U.S. Medicare population. Respir Med 102(9):1248–56. 4. Willsie, S.k. following the GolD Standard. Treating CoPD in Primary Care. Presented at American College of osteopathic family Physicians 47th Annual Convention and Scientific Seminars. March 18–21, 2010. las Vegas, Nevada. 5. Negro, R.D. 2008. optimizing economic outcomes in the management of CoPD. Int J Chron Obstruct Pulmon Dis 3(1): 1–10. 6. National Committee on Quality Assurance. 2009. Insights for Improvement: Advancing COPD Care Through Quality Measurement. http://www.ncqa.org/portals/0/publications/NCQA_Insights_Improvement_fINAl.pdf (May 27, 2011) 7. Global Initiative for chronic obstructive lung disease. 2010. Global strategy for the diagnosis, management, and prevention of CoPD. www.goldcopd.com (May 27, 2011) annual MonItorIng for PatIEnts on PErsIstEnt MEdICatIons 1. Center for Disease Control and Prevention. 2008. Medication Safety Basics. http://www.cdc.gov/MedicationSafety/basics.html (June 1, 2011) 2. Avorn, J., 2010. Medication Use in older Patients: better Policy Could Encourage better Practice. JAMA 304(14):1606–7. 3. budnitz, D., et al., 2006. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 296:1858–66. 4. U.S. food and Drug Administration. 2010. Safe Use Initiative Fact Sheet. http://www.fda.gov/Drugs/DrugSafety/ucm188760.htm (June 1, 2011) 5. Slone Epidemiology Center at boston University. 2006. Patterns of medication use in the United States. http://www.bu.edu/slone/ SloneSurvey/AnnualRpt/SloneSurveyWebReport2006.pdf (June 1, 2011) 6. Classen D.C., et al., 2010. Adverse drug events among hospitalized Medicare patients: Epidemiology and national estimates from a new approach to surveillance. Jt Comm J Qual Patient Saf 36:12–21. 7. Hohl, C.M., b. Nosyk, l. kuramoto, et al., 2011. outcomes of emergency department patients presenting with adverse drug events. Ann Emerg Med DoI:10.1016/j.annemergmed.2011.01.003 antIdEPrEssant MEdICatIon ManagEMEnt 1. The National Alliance on Mental Illness. 2009. Major Depression Fact Sheet. http://www.nami.org/Template.cfm?Section=Depression&Te mplate=/ContentManagement/ContentDisplay.cfm&ContentID=88956 (May 31, 2011) 2. Department of Veteran Affairs, Department of Defense. 2009. VA/DoD clinical practice guideline for management of major depressive disorder (MDD). http://www.healthquality.va.gov/MDD_fUll_3c.pdf (May 31, 2011) 3. Institute for Clinical Systems Improvement (ICSI). 2010. Major depression in adults in primary care. http://www.guideline.gov/content.as px?id=23857&search=major+depression (May 31, 2011) 4. McIntyre, R.S., S. liauw, V.H. Taylor. 2011. Depression in the workforce: the intermediary effect of medical comorbidity. Journal of Affective Disorders. 128(1):S29–S36. 5. Smith, J.P., G.C. Smith. 2010. long-term economic costs of psychological problems during childhood. Social Science and Medicine. 71(1):110–15. 6. Johnston, k., W. Westerfield, S. Momim, R. Phillipi. 2009. The direct and indirect costs of employee depression, anxiety, and emotional disorders—An employer case study. J of Occ and Envt Med. 51(5):564–77. 7. birnbaum, H.G., kessler, R.C., kelley, D., ben-Hamadi, R., Joish, V.N., Greenberg, P.E. 2010. Employer burden of mild, moderate, and severe major depressive disorder: mental health services utilization and costs, and work performance. Depression and Anxiety. 27(1):78–89. 8. Wang, J., N. Schmitz N. 2010. Does job strain interact with psychosocial factors outside of the workplace in relation to the risk of major depression? The Canadian National Population Health Survey. Soc. Psychiatry. [Epub ahead of print]. 9. American Psychiatric Association. 2010 Practice guideline for the treatment of patients with major depressive disorder. Third edition. http://www.guideline.gov/content.aspx?id=24158 (May 31, 2011) 10. lauber, C., J.l. bowen. 2010. low mood and employment: when affective disorders are intertwined with the workplace—a Uk perspective. Int. Rev. Psychiatry. 22(2):173–82. 11. Hunot, V.M., R. Horne, M.N. leese, R.C. Churchill. 2007. A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences. Prim Care Companion J Clin Psychiatry. 9:91–9.
Page 1 and 2:
Continuous Improvement and the Expa
Page 3 and 4:
2 This Report and the data containe
Page 5 and 6:
4 N AT I o N A l C o M M I T T E E
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
top 10 and bottom 10 states “loca
Page 15 and 16:
Page 17 and 18:
16 this measure has shown steady ga
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
24 HEDIS MEASURES of CARE about HEd
Page 27 and 28:
S A f E T y A N D P o T E N T I A l
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
W E l l N E S S A N D P R E V E N T
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
C H R o N I C D I S E A S E M A N A
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
M E A S U R E S T A R G E T E D A T
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
C o N S U M E R A N D P A T I E N T
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
128 N AT I o N A l C o M M I T T E
Page 131 and 132:
130 APPENDIx 1: HEDIS EffECTIVENESS
Page 133 and 134:
Page 135 and 136:
134 APPENDIx 2: HEDIS EffECTIVENESS
Page 137 and 138:
Page 139 and 140: 138 N AT I o N A l C o M M I T T E
Page 143 and 144: 142 APPENDIx 4b: ACCREDITED VS. NoN
Page 149 and 150: 148 APPENDIx 6A: ACCREDITED VS. NoN
Page 151 and 152: 150 APPENDIx 6b: ACCREDITED VS. NoN
Page 153 and 154: 152 APPENDIx 7A: PUblICly REPoRTING
Page 159 and 160: 158 APPENDIx 8: PUblICly REPoRTING
Page 173 and 174: 172 MEASURE N AT I o N A l C o M M
Page 175 and 176: 174 APPENDIx 14b: VARIATIoN IN PlAN
Page 181 and 182: 180 APPENDIx 16A: VARIATIoN IN PlAN
Page 183 and 184: 182 APPENDIx 16b: VARIATIoN IN PlAN
Page 185 and 186: 184 REfERENCES N AT I o N A l C o M
Page 189: 188 N AT I o N A l C o M M I T T E
Page 200 and 201: ACkNoWlEDGMENTS Health Plans The 20
show all

Continuous Improvement and the Expansion of Quality ... - NCQA

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?